Rankings
▼
Calendar
MNKD FY 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$813M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$65M
+3.3% YoY
Gross Profit
$41M
62.2% margin
Operating Income
-$48M
-73.5% margin
Net Income
-$57M
-87.9% margin
EPS (Diluted)
$-0.26
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$33M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$109M
Total Liabilities
$289M
Stockholders' Equity
-$180M
Cash & Equivalents
$67M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$63M
+3.3%
Gross Profit
$41M
$35M
+15.5%
Operating Income
-$48M
-$45M
-7.4%
Net Income
-$57M
-$52M
-10.3%
← Q4 2019
All Quarters
Q1 2020 →